| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.02e-05 | 114 | 131 | 7 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 1.77e-05 | 124 | 131 | 7 | GO:0101005 | |
| GeneOntologyMolecularFunction | zinc ion binding | MBTD1 LITAFD KDM4C RNF19A RNF8 TRIM27 ADA PIAS2 CREBBP PIAS4 LHX1 ATXN7L3 TRAF4 PIAS3 EHMT2 PRKCG TRIM37 EP300 | 2.12e-05 | 891 | 131 | 18 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | MBTD1 LITAFD KDM4C RNF19A RNF8 CYGB ADNP TRIM27 ADA PIAS2 CREBBP PIAS4 LHX1 ATXN7L3 MELTF TRAF4 PIAS3 EHMT2 PRKCG TRIM37 EP300 | 3.06e-05 | 1189 | 131 | 21 | GO:0046914 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 3.38e-05 | 137 | 131 | 7 | GO:0019783 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 4.27e-05 | 2 | 131 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 4.27e-05 | 2 | 131 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 8.86e-05 | 36 | 131 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.28e-04 | 3 | 131 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | folic acid receptor activity | 1.28e-04 | 3 | 131 | 2 | GO:0061714 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 1.45e-04 | 16 | 131 | 3 | GO:0004697 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 2.79e-04 | 192 | 131 | 7 | GO:0008234 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.90e-04 | 20 | 131 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RNF19A RNF149 RNF8 TRIM27 PIAS2 RFPL4AL1 PIAS4 RFPL4A PIAS3 TRIM37 | 3.00e-04 | 398 | 131 | 10 | GO:0061659 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.22e-04 | 5 | 131 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RNF19A RNF149 RNF8 TRIM27 PIAS2 RFPL4AL1 PIAS4 RFPL4A PIAS3 ZFP91 TRIM37 | 5.64e-04 | 512 | 131 | 11 | GO:0019787 |
| GeneOntologyMolecularFunction | microfibril binding | 6.30e-04 | 6 | 131 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RNF19A RNF149 RNF8 TRIM27 PIAS2 RFPL4AL1 PIAS4 RFPL4A PIAS3 ZFP91 TRIM37 | 7.73e-04 | 532 | 131 | 11 | GO:0016755 |
| GeneOntologyMolecularFunction | transcription coregulator activity | SFMBT1 KDM4C TRIM27 PIAS2 CREBBP PIAS4 ATXN7L3 PIAS3 ARID5B TRIM37 EP300 | 1.20e-03 | 562 | 131 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.29e-03 | 182 | 131 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.30e-03 | 33 | 131 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.36e-03 | 184 | 131 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.64e-03 | 334 | 131 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RNF19A RNF149 RNF8 TRIM27 PIAS2 CREBBP RFPL4AL1 PIAS4 RFPL4A PIAS3 ZFP91 TRIM37 EP300 | 1.77e-03 | 775 | 131 | 13 | GO:0016746 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.94e-03 | 343 | 131 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.48e-03 | 86 | 131 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 2.63e-03 | 42 | 131 | 3 | GO:0071889 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 2.70e-03 | 12 | 131 | 2 | GO:0001851 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L4 USP17L2 USP17L1 RNF19A USP9X RNF149 RNF8 TRIM27 PIAS2 RFPL4AL1 PIAS4 RFPL4A PIAS3 ZFP91 USP17L3 PRKCE PRKCG USP54 TRIM37 USP17L8 | 5.13e-06 | 1009 | 130 | 20 | GO:0070647 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | RELN TRIM27 CREBBP RFPL4AL1 RFPL4A ARID5B PRKCZ TRIM37 EP300 CARD14 | 6.23e-06 | 261 | 130 | 10 | GO:0051091 |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 8.79e-06 | 162 | 130 | 8 | GO:0018205 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L4 USP17L2 USP17L1 RNF19A USP9X RNF149 RNF8 TRIM27 PIAS2 RFPL4AL1 PIAS4 RFPL4A PIAS3 ZFP91 USP17L3 PRKCE PRKCG USP54 TRIM37 USP17L8 | 1.28e-05 | 1074 | 130 | 20 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein deubiquitination | 1.45e-05 | 125 | 130 | 7 | GO:0016579 | |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | RELN TRIM27 PIAS2 CREBBP RFPL4AL1 PIAS4 RFPL4A ARID5B PRKCZ TRIM37 EP300 CARD14 | 2.77e-05 | 449 | 130 | 12 | GO:0051090 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 3.61e-05 | 144 | 130 | 7 | GO:0070646 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell differentiation | 5.21e-05 | 64 | 130 | 5 | GO:0046638 | |
| GeneOntologyBiologicalProcess | lateral motor column neuron migration | 1.18e-04 | 3 | 130 | 2 | GO:0097477 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.29e-04 | 373 | 130 | 10 | GO:0007611 | |
| GeneOntologyBiologicalProcess | activation of NF-kappaB-inducing kinase activity | 1.56e-04 | 17 | 130 | 3 | GO:0007250 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 1.68e-04 | 44 | 130 | 4 | GO:1905168 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 1.80e-04 | 83 | 130 | 5 | GO:0010569 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1C CACNA1D RELN KCNH7 ANK2 PIEZO1 ANO1 PIAS3 KCNH1 PRKCE PRKCZ KCNH5 | 2.21e-04 | 559 | 130 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | spinal cord motor neuron migration | 2.35e-04 | 4 | 130 | 2 | GO:0097476 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 2.35e-04 | 4 | 130 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | long-term memory | 2.36e-04 | 48 | 130 | 4 | GO:0007616 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell activation | 2.50e-04 | 89 | 130 | 5 | GO:0046635 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell differentiation | 3.07e-04 | 93 | 130 | 5 | GO:0046637 | |
| GeneOntologyBiologicalProcess | embryonic cranial skeleton morphogenesis | 3.23e-04 | 52 | 130 | 4 | GO:0048701 | |
| Domain | UCH | 6.18e-07 | 71 | 130 | 7 | PF00443 | |
| Domain | USP_2 | 6.18e-07 | 71 | 130 | 7 | PS00973 | |
| Domain | USP_3 | 6.81e-07 | 72 | 130 | 7 | PS50235 | |
| Domain | USP_dom | 6.81e-07 | 72 | 130 | 7 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 6.81e-07 | 72 | 130 | 7 | IPR001394 | |
| Domain | PINIT | 1.31e-06 | 4 | 130 | 3 | PS51466 | |
| Domain | PINIT | 1.31e-06 | 4 | 130 | 3 | PF14324 | |
| Domain | PINIT | 1.31e-06 | 4 | 130 | 3 | IPR023321 | |
| Domain | USP_1 | 9.22e-06 | 70 | 130 | 6 | PS00972 | |
| Domain | zf-MIZ | 1.13e-05 | 7 | 130 | 3 | PF02891 | |
| Domain | ZF_SP_RING | 1.13e-05 | 7 | 130 | 3 | PS51044 | |
| Domain | Znf_MIZ | 1.80e-05 | 8 | 130 | 3 | IPR004181 | |
| Domain | PAS_9 | 3.82e-05 | 10 | 130 | 3 | PF13426 | |
| Domain | Nuc_rcpt_coact_CREBbp | 4.81e-05 | 2 | 130 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 4.81e-05 | 2 | 130 | 2 | SM00551 | |
| Domain | Ribosomal_L44e | 4.81e-05 | 2 | 130 | 2 | IPR000552 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 4.81e-05 | 2 | 130 | 2 | IPR010303 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 4.81e-05 | 2 | 130 | 2 | PF09030 | |
| Domain | Ribosomal_L44e | 4.81e-05 | 2 | 130 | 2 | PD002841 | |
| Domain | zf-TAZ | 4.81e-05 | 2 | 130 | 2 | PF02135 | |
| Domain | ZF_TAZ | 4.81e-05 | 2 | 130 | 2 | PS50134 | |
| Domain | RIBOSOMAL_L44E | 4.81e-05 | 2 | 130 | 2 | PS01172 | |
| Domain | KAT11 | 4.81e-05 | 2 | 130 | 2 | SM01250 | |
| Domain | Znf_TAZ | 4.81e-05 | 2 | 130 | 2 | IPR000197 | |
| Domain | KIX | 4.81e-05 | 2 | 130 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 4.81e-05 | 2 | 130 | 2 | PF08214 | |
| Domain | KIX | 4.81e-05 | 2 | 130 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 4.81e-05 | 2 | 130 | 2 | IPR031162 | |
| Domain | Ribosomal_L44 | 4.81e-05 | 2 | 130 | 2 | PF00935 | |
| Domain | DUF902 | 4.81e-05 | 2 | 130 | 2 | PF06001 | |
| Domain | K_chnl_volt-dep_EAG | 4.81e-05 | 2 | 130 | 2 | IPR003949 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 4.81e-05 | 2 | 130 | 2 | IPR013178 | |
| Domain | KIX_dom | 4.81e-05 | 2 | 130 | 2 | IPR003101 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 3.10.450.80 | |
| Domain | CBP_P300_HAT | 4.81e-05 | 2 | 130 | 2 | PS51727 | |
| Domain | - | KDM4C RNF19A RNF149 RNF8 TRIM27 PIAS2 RFPL4AL1 PIAS4 TRAF4 RFPL4A PIAS3 TRIM37 | 7.16e-05 | 449 | 130 | 12 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | KDM4C RNF19A RNF149 RNF8 TRIM27 PIAS2 RFPL4AL1 PIAS4 TRAF4 RFPL4A PIAS3 TRIM37 | 8.82e-05 | 459 | 130 | 12 | IPR013083 |
| Domain | USP_CS | 9.62e-05 | 66 | 130 | 5 | IPR018200 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.13e-04 | 14 | 130 | 3 | IPR003938 | |
| Domain | CAC1F_C | 1.44e-04 | 3 | 130 | 2 | IPR031688 | |
| Domain | CAC1F_C | 1.44e-04 | 3 | 130 | 2 | PF16885 | |
| Domain | VDCC_L_a1su | 2.86e-04 | 4 | 130 | 2 | IPR005446 | |
| Domain | PBC | 2.86e-04 | 4 | 130 | 2 | PF03792 | |
| Domain | PBX | 2.86e-04 | 4 | 130 | 2 | IPR005542 | |
| Domain | DAG/PE-bd | 4.00e-04 | 21 | 130 | 3 | IPR020454 | |
| Domain | - | 4.00e-04 | 21 | 130 | 3 | 1.10.720.30 | |
| Domain | SAP | 4.61e-04 | 22 | 130 | 3 | PF02037 | |
| Domain | RDM_domain_RFPL | 4.74e-04 | 5 | 130 | 2 | IPR022723 | |
| Domain | RDM | 4.74e-04 | 5 | 130 | 2 | PF11002 | |
| Domain | Folate_rcpt | 4.74e-04 | 5 | 130 | 2 | IPR004269 | |
| Domain | SAP | 5.27e-04 | 23 | 130 | 3 | SM00513 | |
| Domain | PAS-assoc_C | 5.99e-04 | 24 | 130 | 3 | IPR000700 | |
| Domain | SAP | 6.78e-04 | 25 | 130 | 3 | PS50800 | |
| Domain | SAP_dom | 6.78e-04 | 25 | 130 | 3 | IPR003034 | |
| Domain | Nuc_rcpt_coact | 7.08e-04 | 6 | 130 | 2 | IPR009110 | |
| Domain | PAC | 7.62e-04 | 26 | 130 | 3 | IPR001610 | |
| Domain | PAC | 7.62e-04 | 26 | 130 | 3 | PS50113 | |
| Domain | PAC | 7.62e-04 | 26 | 130 | 3 | SM00086 | |
| Domain | Growth_fac_rcpt_ | 7.85e-04 | 156 | 130 | 6 | IPR009030 | |
| Domain | EGF_extracell | 8.08e-04 | 60 | 130 | 4 | IPR013111 | |
| Domain | EGF_2 | 8.08e-04 | 60 | 130 | 4 | PF07974 | |
| Domain | TSP_1 | 9.72e-04 | 63 | 130 | 4 | PF00090 | |
| Domain | TB | 9.87e-04 | 7 | 130 | 2 | PF00683 | |
| Domain | Ca_chan_IQ | 9.87e-04 | 7 | 130 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 9.87e-04 | 7 | 130 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 9.87e-04 | 7 | 130 | 2 | IPR014873 | |
| Domain | GPHH | 9.87e-04 | 7 | 130 | 2 | PF16905 | |
| Domain | GPHH_dom | 9.87e-04 | 7 | 130 | 2 | IPR031649 | |
| Domain | TSP1 | 1.09e-03 | 65 | 130 | 4 | SM00209 | |
| Domain | TSP1_rpt | 1.09e-03 | 65 | 130 | 4 | IPR000884 | |
| Domain | TSP1 | 1.09e-03 | 65 | 130 | 4 | PS50092 | |
| Domain | ZF_RING_2 | 1.16e-03 | 298 | 130 | 8 | PS50089 | |
| Domain | Ion_trans_dom | 1.21e-03 | 114 | 130 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.21e-03 | 114 | 130 | 5 | PF00520 | |
| Domain | - | 1.31e-03 | 8 | 130 | 2 | 3.90.290.10 | |
| Domain | Folate_rec | 1.31e-03 | 8 | 130 | 2 | PF03024 | |
| Domain | Folate_rcpt-like | 1.31e-03 | 8 | 130 | 2 | IPR018143 | |
| Domain | CNMP_BINDING_1 | 1.41e-03 | 32 | 130 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.41e-03 | 32 | 130 | 3 | PS00889 | |
| Domain | PAS | 1.41e-03 | 32 | 130 | 3 | SM00091 | |
| Domain | MBT | 1.68e-03 | 9 | 130 | 2 | SM00561 | |
| Domain | MBT | 1.68e-03 | 9 | 130 | 2 | PS51079 | |
| Domain | TB_dom | 1.68e-03 | 9 | 130 | 2 | IPR017878 | |
| Domain | Ribosomal_zn-bd | 1.68e-03 | 9 | 130 | 2 | IPR011332 | |
| Domain | TB | 1.68e-03 | 9 | 130 | 2 | PS51364 | |
| Domain | cNMP | 1.68e-03 | 34 | 130 | 3 | SM00100 | |
| Domain | PAS | 1.68e-03 | 34 | 130 | 3 | PS50112 | |
| Domain | PAS | 1.68e-03 | 34 | 130 | 3 | IPR000014 | |
| Domain | cNMP_binding | 1.68e-03 | 34 | 130 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 1.83e-03 | 35 | 130 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.83e-03 | 35 | 130 | 3 | PS50042 | |
| Domain | Znf_RING | 2.04e-03 | 326 | 130 | 8 | IPR001841 | |
| Domain | MBT | 2.09e-03 | 10 | 130 | 2 | PF02820 | |
| Domain | Mbt | 2.09e-03 | 10 | 130 | 2 | IPR004092 | |
| Domain | VDCCAlpha1 | 2.09e-03 | 10 | 130 | 2 | IPR002077 | |
| Domain | Pkinase_C | 2.15e-03 | 37 | 130 | 3 | IPR017892 | |
| Domain | cNMP-bd-like | 2.33e-03 | 38 | 130 | 3 | IPR018490 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L4 GBF1 USP17L2 ANK2 USP17L1 FOLR2 USP9X CFP ST8SIA1 THSD7B MBD6 TRIM27 PIAS2 CREBBP PIAS4 TGFBR2 PTP4A2 MELTF IGFBP5 PIAS3 ADAMTS7 LYPD5 USP17L3 LTBP1 EP300 USP17L8 | 3.77e-06 | 1475 | 96 | 26 | M19806 |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.16e-05 | 44 | 96 | 5 | M27295 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.30e-05 | 45 | 96 | 5 | MM15671 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L4 GBF1 USP17L2 USP17L1 FOLR2 USP9X FOLR3 CFP ST8SIA1 THSD7B MBD6 TRIM27 PIAS2 PIAS4 PTP4A2 MELTF IGFBP5 PIAS3 ADAMTS7 LYPD5 USP17L3 LTBP1 EP300 USP17L8 | 1.39e-05 | 1389 | 96 | 24 | MM15307 |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.29e-05 | 25 | 96 | 4 | M39713 | |
| Pathway | PID_NFAT_3PATHWAY | 2.92e-05 | 53 | 96 | 5 | M113 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.56e-05 | 91 | 96 | 6 | M39700 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.28e-05 | 94 | 96 | 6 | M1041 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.53e-04 | 40 | 96 | 4 | MM15000 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS | 1.61e-04 | 16 | 96 | 3 | MM14938 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.77e-04 | 77 | 96 | 5 | MM14670 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.94e-04 | 17 | 96 | 3 | MM1509 | |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L4 USP17L2 USP17L1 USP9X MBD6 TGFBR2 USP17L3 EP300 USP17L8 | 1.99e-04 | 299 | 96 | 9 | M27574 |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.66e-04 | 84 | 96 | 5 | M3228 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.74e-04 | 19 | 96 | 3 | M18933 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 2.88e-04 | 47 | 96 | 4 | M19708 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS | 3.21e-04 | 20 | 96 | 3 | M27237 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.67e-04 | 325 | 96 | 9 | M12868 | |
| Pathway | REACTOME_DEUBIQUITINATION | 4.14e-04 | 262 | 96 | 8 | MM15286 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 4.29e-04 | 22 | 96 | 3 | MM1443 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 4.53e-04 | 5 | 96 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 4.53e-04 | 5 | 96 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 4.53e-04 | 5 | 96 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 4.53e-04 | 5 | 96 | 2 | M27228 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 4.58e-04 | 53 | 96 | 4 | MM15880 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 4.91e-04 | 23 | 96 | 3 | M2821 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 5.28e-04 | 55 | 96 | 4 | M39351 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 6.24e-04 | 101 | 96 | 5 | M39387 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 6.24e-04 | 101 | 96 | 5 | MM15829 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 6.76e-04 | 6 | 96 | 2 | M22062 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 6.76e-04 | 6 | 96 | 2 | M47880 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 6.76e-04 | 6 | 96 | 2 | M47762 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 6.90e-04 | 59 | 96 | 4 | M39886 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 8.04e-04 | 161 | 96 | 6 | M27871 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 8.86e-04 | 28 | 96 | 3 | MM15042 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 9.43e-04 | 7 | 96 | 2 | MM1573 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 9.95e-04 | 65 | 96 | 4 | M39682 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.09e-03 | 30 | 96 | 3 | M207 | |
| Pathway | PID_RAS_PATHWAY | 1.09e-03 | 30 | 96 | 3 | M269 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.09e-03 | 30 | 96 | 3 | M27323 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.25e-03 | 8 | 96 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.25e-03 | 8 | 96 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.25e-03 | 8 | 96 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.25e-03 | 8 | 96 | 2 | M46443 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.26e-03 | 118 | 96 | 5 | MM15588 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.31e-03 | 70 | 96 | 4 | M3115 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.53e-03 | 73 | 96 | 4 | M638 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 1.57e-03 | 34 | 96 | 3 | M39771 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.60e-03 | 9 | 96 | 2 | M47451 | |
| Pathway | REACTOME_SUMOYLATION | 1.83e-03 | 189 | 96 | 6 | M27214 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.93e-03 | 191 | 96 | 6 | MM15289 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.99e-03 | 10 | 96 | 2 | M27945 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.17e-03 | 38 | 96 | 3 | MM14874 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.34e-03 | 39 | 96 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.34e-03 | 39 | 96 | 3 | MM15165 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.34e-03 | 39 | 96 | 3 | M27238 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.35e-03 | 82 | 96 | 4 | M2 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.43e-03 | 11 | 96 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.43e-03 | 11 | 96 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.43e-03 | 11 | 96 | 2 | M26924 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 2.46e-03 | 83 | 96 | 4 | M39637 | |
| Pathway | PID_IFNG_PATHWAY | 2.52e-03 | 40 | 96 | 3 | M161 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.55e-03 | 272 | 96 | 7 | M29619 | |
| Pathway | PID_CMYB_PATHWAY | 2.57e-03 | 84 | 96 | 4 | M195 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 2.70e-03 | 41 | 96 | 3 | MM14546 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.70e-03 | 41 | 96 | 3 | M512 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 2.80e-03 | 86 | 96 | 4 | M39375 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 2.80e-03 | 86 | 96 | 4 | M2642 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.90e-03 | 12 | 96 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.90e-03 | 12 | 96 | 2 | M27765 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 2.90e-03 | 12 | 96 | 2 | M47628 | |
| Pathway | WP_TGFB_SMAD_SIGNALING | 2.90e-03 | 12 | 96 | 2 | M48091 | |
| Pathway | REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS | 2.90e-03 | 12 | 96 | 2 | M27404 | |
| Pathway | REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS | 2.90e-03 | 12 | 96 | 2 | MM15157 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.90e-03 | 42 | 96 | 3 | M7169 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 2.03e-10 | 10 | 135 | 5 | 24207026 | |
| Pubmed | 6.34e-10 | 12 | 135 | 5 | 24695638 | ||
| Pubmed | 1.08e-09 | 5 | 135 | 4 | 15907835 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.59e-09 | 14 | 135 | 5 | 11793228 | |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 9.10e-09 | 19 | 135 | 5 | 28067227 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | MBTD1 AHCYL1 POGZ MBD6 PIAS2 CREBBP ZBTB14 PIAS4 RESF1 EHMT2 ARID5B EP300 | 1.41e-08 | 351 | 135 | 12 | 38297188 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | 1.58e-08 | 21 | 135 | 5 | 8622927 | |
| Pubmed | 1.58e-08 | 21 | 135 | 5 | 14583620 | ||
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | 1.58e-08 | 21 | 135 | 5 | 11468161 | |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | 1.58e-08 | 21 | 135 | 5 | 8756639 | |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | 1.58e-08 | 21 | 135 | 5 | 12447969 | |
| Pubmed | 1.58e-08 | 21 | 135 | 5 | 18980247 | ||
| Pubmed | 2.04e-08 | 22 | 135 | 5 | 9154835 | ||
| Pubmed | NDST1 AHCYL1 RELN VWF ANK2 KDM4C USP9X POGZ PIAS2 CREBBP GTF3A PIAS3 EHMT2 ZNF197 ARID5B CCN2 USP54 EIF2AK1 PBX3 TRIM37 EP300 | 2.65e-08 | 1285 | 135 | 21 | 35914814 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | 3.28e-08 | 24 | 135 | 5 | 8995226 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 3.36e-08 | 125 | 135 | 8 | 32891193 | |
| Pubmed | 4.08e-08 | 25 | 135 | 5 | 21115691 | ||
| Pubmed | 5.04e-08 | 26 | 135 | 5 | 35816173 | ||
| Pubmed | 9.01e-08 | 29 | 135 | 5 | 32527007 | ||
| Pubmed | Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis. | 1.05e-07 | 12 | 135 | 4 | 30612578 | |
| Pubmed | MBTD1 AHCYL1 RPL36AL RPL36A USP9X POGZ RFC1 MBD6 ADNP PIAS2 CREBBP ZBTB14 LHX1 ATXN7L3 RESF1 EHMT2 RRP12 ZFP91 ARID5B USP54 EP300 | 1.58e-07 | 1429 | 135 | 21 | 35140242 | |
| Pubmed | 1.78e-07 | 33 | 135 | 5 | 20228807 | ||
| Pubmed | 2.08e-07 | 34 | 135 | 5 | 20403174 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 2.08e-07 | 34 | 135 | 5 | 14699124 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 2.08e-07 | 34 | 135 | 5 | 15780755 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 2.08e-07 | 34 | 135 | 5 | 19188362 | |
| Pubmed | 2.08e-07 | 34 | 135 | 5 | 11941478 | ||
| Pubmed | 2.08e-07 | 34 | 135 | 5 | 17109758 | ||
| Pubmed | 2.08e-07 | 34 | 135 | 5 | 20388806 | ||
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 2.08e-07 | 34 | 135 | 5 | 20715989 | |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 2.08e-07 | 34 | 135 | 5 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 2.08e-07 | 34 | 135 | 5 | 20368735 | |
| Pubmed | 2.08e-07 | 34 | 135 | 5 | 10936051 | ||
| Pubmed | 2.08e-07 | 34 | 135 | 5 | 21448158 | ||
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | 2.42e-07 | 35 | 135 | 5 | 16611142 | |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | 2.42e-07 | 35 | 135 | 5 | 21239494 | |
| Pubmed | 2.80e-07 | 36 | 135 | 5 | 20147298 | ||
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | 3.23e-07 | 37 | 135 | 5 | 20228808 | |
| Pubmed | 5.69e-07 | 5 | 135 | 3 | 2590242 | ||
| Pubmed | AHCYL1 RPL36AL RPL36A USP9X CREBBP PIAS4 PTP4A2 EHMT2 KCNH1 PRKCE PRKCG PRKCZ EP300 KCNH5 | 1.05e-06 | 730 | 135 | 14 | 34857952 | |
| Pubmed | SUMOylation of RORalpha potentiates transcriptional activation function. | 1.13e-06 | 6 | 135 | 3 | 19041634 | |
| Pubmed | Protein kinase C-theta is specifically localized on centrosomes and kinetochores in mitotic cells. | 1.13e-06 | 6 | 135 | 3 | 9854032 | |
| Pubmed | 1.13e-06 | 6 | 135 | 3 | 10879655 | ||
| Pubmed | The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions. | 1.13e-06 | 6 | 135 | 3 | 12093536 | |
| Pubmed | An immunohistochemical study of protein kinase C distribution in fetal mouse vertebral column. | 1.13e-06 | 6 | 135 | 3 | 7985811 | |
| Pubmed | A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. | 1.13e-06 | 6 | 135 | 3 | 23704280 | |
| Pubmed | 1.22e-06 | 48 | 135 | 5 | 16421571 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C RASA2 VPS13C FRMPD2 TMEM63C NBEAP1 CREBBP ITPKB PIAS4 CMIP LPP ARID5B PRKCE PPIE ANKRD12 PRKCZ PBX3 RPS6KL1 EP300 CEP170B | 1.30e-06 | 1489 | 135 | 20 | 28611215 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.51e-06 | 50 | 135 | 5 | 31806660 | |
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 7588787 | ||
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 15381704 | ||
| Pubmed | 1.98e-06 | 7 | 135 | 3 | 9724754 | ||
| Pubmed | Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance. | 1.98e-06 | 7 | 135 | 3 | 36535926 | |
| Pubmed | 2.67e-06 | 56 | 135 | 5 | 34170322 | ||
| Pubmed | 2.91e-06 | 57 | 135 | 5 | 18022353 | ||
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 8922669 | ||
| Pubmed | PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments. | 3.16e-06 | 8 | 135 | 3 | 12134071 | |
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 7606770 | ||
| Pubmed | Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). | 3.16e-06 | 8 | 135 | 3 | 14691252 | |
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 16522640 | ||
| Pubmed | Protein-protein interaction of zinc finger LIM domains with protein kinase C. | 3.16e-06 | 8 | 135 | 3 | 8940095 | |
| Pubmed | 3.16e-06 | 8 | 135 | 3 | 15894802 | ||
| Pubmed | Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation. | 3.16e-06 | 8 | 135 | 3 | 10212259 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MBTD1 USP9X RNF8 TSC1 PIAS2 CREBBP PIAS4 SETD2 RESF1 ARID5B TRIM37 CEP170B | 3.42e-06 | 588 | 135 | 12 | 38580884 |
| Pubmed | KLF11 ZNF174 POGZ CREBBP ZBTB14 RFPL4AL1 PIAS4 LHX1 RFPL4A GTF3A PIAS3 SNAI2 PBX3 | 4.23e-06 | 709 | 135 | 13 | 22988430 | |
| Pubmed | The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription. | 4.72e-06 | 9 | 135 | 3 | 14612417 | |
| Pubmed | Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. | 4.72e-06 | 9 | 135 | 3 | 7876252 | |
| Pubmed | FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation. | 4.72e-06 | 9 | 135 | 3 | 28533443 | |
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 10391924 | ||
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 8473314 | ||
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 4.72e-06 | 9 | 135 | 3 | 27325115 | |
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 17203073 | ||
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 7850771 | ||
| Pubmed | 4.72e-06 | 9 | 135 | 3 | 8206685 | ||
| Pubmed | An acetylation switch regulates SUMO-dependent protein interaction networks. | 4.72e-06 | 9 | 135 | 3 | 22578841 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.07e-06 | 248 | 135 | 8 | 24006456 | |
| Pubmed | 6.73e-06 | 10 | 135 | 3 | 1970444 | ||
| Pubmed | Interplay between protein acetylation and ubiquitination controls MCL1 protein stability. | 6.73e-06 | 10 | 135 | 3 | 34758305 | |
| Pubmed | Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate. | 6.73e-06 | 10 | 135 | 3 | 26503718 | |
| Pubmed | Human immunodeficiency virus induces phosphorylation of its cell surface receptor. | 6.73e-06 | 10 | 135 | 3 | 3259291 | |
| Pubmed | Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates. | 6.73e-06 | 10 | 135 | 3 | 10491200 | |
| Pubmed | 6.73e-06 | 10 | 135 | 3 | 2139676 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | KDM4C ZNF174 PBX4 RFC1 TRIM27 PIAS2 CREBBP PIAS4 LHX1 ANKRD33 PIAS3 EHMT2 PBX3 EP300 | 8.62e-06 | 877 | 135 | 14 | 20211142 |
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 14613966 | ||
| Pubmed | IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. | 9.22e-06 | 11 | 135 | 3 | 8599832 | |
| Pubmed | Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. | 9.22e-06 | 11 | 135 | 3 | 2182321 | |
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 11104762 | ||
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 27009683 | ||
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 8914829 | ||
| Pubmed | Expression profile of protein kinase C isozymes in preimplantation mouse development. | 9.22e-06 | 11 | 135 | 3 | 16183862 | |
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 25834049 | ||
| Pubmed | 9.22e-06 | 11 | 135 | 3 | 28842558 | ||
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 11919157 | ||
| Pubmed | Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium. | 1.23e-05 | 12 | 135 | 3 | 11141237 | |
| Pubmed | HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? | 1.23e-05 | 12 | 135 | 3 | 18577246 | |
| Pubmed | 1.23e-05 | 12 | 135 | 3 | 19363595 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.50e-05 | 2 | 135 | 2 | 34845315 | |
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 25858550 | ||
| Pubmed | 1.50e-05 | 2 | 135 | 2 | 19729597 | ||
| Interaction | SNAI2 interactions | 1.46e-08 | 46 | 127 | 7 | int:SNAI2 | |
| Interaction | ZMYM2 interactions | SFMBT1 ZNF174 POGZ ST8SIA1 ADNP PIAS2 CREBBP PIAS4 RESF1 EHMT2 | 8.61e-06 | 271 | 127 | 10 | int:ZMYM2 |
| Interaction | KLF3 interactions | 1.45e-05 | 228 | 127 | 9 | int:KLF3 | |
| Interaction | ATF7IP interactions | 2.73e-05 | 138 | 127 | 7 | int:ATF7IP | |
| Interaction | HOXD4 interactions | 3.63e-05 | 30 | 127 | 4 | int:HOXD4 | |
| Interaction | KLF8 interactions | MBTD1 RPL36AL RPL36A POGZ ADNP CREBBP ZBTB14 EHMT2 RRP12 EP300 | 4.54e-05 | 329 | 127 | 10 | int:KLF8 |
| Interaction | KCNH5 interactions | 5.16e-05 | 12 | 127 | 3 | int:KCNH5 | |
| Cytoband | 8p23.1 | 9.71e-05 | 154 | 135 | 5 | 8p23.1 | |
| Cytoband | 6q23.1 | 1.28e-04 | 6 | 135 | 2 | 6q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 6.67e-04 | 234 | 135 | 5 | chr8p23 | |
| GeneFamily | Zinc fingers MIZ-type | 5.16e-06 | 7 | 97 | 3 | 85 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.70e-04 | 4 | 97 | 2 | 628 | |
| GeneFamily | Ring finger proteins | 6.99e-04 | 275 | 97 | 7 | 58 | |
| GeneFamily | Complement system|Sushi domain containing | 9.40e-04 | 36 | 97 | 3 | 492 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.00e-03 | 9 | 97 | 2 | 1263 | |
| GeneFamily | C2 domain containing protein kinases | 1.25e-03 | 10 | 97 | 2 | 835 | |
| GeneFamily | Potassium voltage-gated channels | 1.28e-03 | 40 | 97 | 3 | 274 | |
| GeneFamily | Ubiquitin specific peptidases | 3.38e-03 | 56 | 97 | 3 | 366 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.55e-03 | 57 | 97 | 3 | 1179 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.68e-03 | 17 | 97 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.12e-03 | 18 | 97 | 2 | 91 | |
| GeneFamily | NLR family | 7.89e-03 | 25 | 97 | 2 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 7.89e-03 | 25 | 97 | 2 | 994 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.51e-03 | 26 | 97 | 2 | 253 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 8.51e-03 | 26 | 97 | 2 | 526 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 7.94e-07 | 144 | 134 | 8 | M5942 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.22e-06 | 180 | 134 | 8 | M8239 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | VWF PGBD1 GPRIN3 ST8SIA1 TRIM27 PIAS2 C2CD5 TG TGFBR2 ZFP91 ARID5B UBASH3B | 1.00e-05 | 498 | 134 | 12 | M1741 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | VWF PGBD1 GPRIN3 ST8SIA1 TRIM27 PIAS2 C2CD5 TG TGFBR2 ZFP91 ARID5B UBASH3B | 1.20e-05 | 507 | 134 | 12 | MM1030 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.11e-05 | 348 | 121 | 10 | gudmap_kidney_adult_Mesangium_Meis_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NDST1 DOCK11 FRMPD2 ANO1 TSC1 RFC1 CREBBP SVEP1 LHX1 RESF1 IGFBP5 ADGRG2 LPP ARID5B ANKRD12 | 4.38e-05 | 790 | 121 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 9.57e-09 | 197 | 135 | 9 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-08 | 200 | 135 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-08 | 177 | 135 | 8 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-08 | 177 | 135 | 8 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-07 | 187 | 135 | 8 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-07 | 188 | 135 | 8 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-07 | 188 | 135 | 8 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.22e-07 | 190 | 135 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-07 | 191 | 135 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.33e-07 | 192 | 135 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-07 | 193 | 135 | 8 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-07 | 193 | 135 | 8 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.55e-07 | 196 | 135 | 8 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-07 | 196 | 135 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-07 | 197 | 135 | 8 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-07 | 197 | 135 | 8 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-07 | 197 | 135 | 8 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-07 | 197 | 135 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-07 | 197 | 135 | 8 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-07 | 197 | 135 | 8 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 1.68e-07 | 198 | 135 | 8 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.68e-07 | 198 | 135 | 8 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-07 | 200 | 135 | 8 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.81e-07 | 200 | 135 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.81e-07 | 200 | 135 | 8 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-07 | 200 | 135 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-07 | 200 | 135 | 8 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.81e-07 | 200 | 135 | 8 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-07 | 200 | 135 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-07 | 200 | 135 | 8 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-07 | 200 | 135 | 8 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-07 | 200 | 135 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-07 | 200 | 135 | 8 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-07 | 200 | 135 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.09e-06 | 175 | 135 | 7 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-06 | 177 | 135 | 7 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-06 | 180 | 135 | 7 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-06 | 181 | 135 | 7 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-06 | 182 | 135 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.41e-06 | 182 | 135 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-06 | 185 | 135 | 7 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.58e-06 | 185 | 135 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-06 | 185 | 135 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.63e-06 | 186 | 135 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.69e-06 | 187 | 135 | 7 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.69e-06 | 187 | 135 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 187 | 135 | 7 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-06 | 187 | 135 | 7 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-06 | 187 | 135 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 187 | 135 | 7 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-06 | 188 | 135 | 7 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-06 | 188 | 135 | 7 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-06 | 188 | 135 | 7 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-06 | 189 | 135 | 7 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.88e-06 | 190 | 135 | 7 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-06 | 190 | 135 | 7 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | (1)_T_CD4_fh|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.95e-06 | 191 | 135 | 7 | 66ddff9a99092cb384b9fb2a3ba95ddbebed67cc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 191 | 135 | 7 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 191 | 135 | 7 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.09e-06 | 193 | 135 | 7 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.09e-06 | 193 | 135 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-06 | 193 | 135 | 7 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Teffector/EM_CD4|blood / Manually curated celltypes from each tissue | 2.16e-06 | 194 | 135 | 7 | 8499c03fa3d5cf9631b128681b13b7fc512b7e63 | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 2.24e-06 | 195 | 135 | 7 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 195 | 135 | 7 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 2.31e-06 | 196 | 135 | 7 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.31e-06 | 196 | 135 | 7 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-06 | 196 | 135 | 7 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-06 | 197 | 135 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.39e-06 | 197 | 135 | 7 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-06 | 197 | 135 | 7 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-06 | 197 | 135 | 7 | ea9332adf753d7e92f89654320543abb9e6142aa | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.39e-06 | 197 | 135 | 7 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-06 | 198 | 135 | 7 | 11f21a4a97da10fc6ae604cb627aa3af749d9dff | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-06 | 198 | 135 | 7 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-06 | 198 | 135 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 2.47e-06 | 198 | 135 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.47e-06 | 198 | 135 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-06 | 198 | 135 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tfh|lymph-node_spleen / Manually curated celltypes from each tissue | 2.47e-06 | 198 | 135 | 7 | fbdd37ca3d4b61f266bf6146662cb300ef67b850 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 2.47e-06 | 198 | 135 | 7 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 199 | 135 | 7 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 199 | 135 | 7 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-06 | 199 | 135 | 7 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 199 | 135 | 7 | 1b74f6fbf2628f335ba5eb49b679d2f72068bbbe | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.56e-06 | 199 | 135 | 7 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 199 | 135 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.56e-06 | 199 | 135 | 7 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 199 | 135 | 7 | a660f7373fca03929234cbd936735f97883fb689 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.56e-06 | 199 | 135 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | proximal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.64e-06 | 200 | 135 | 7 | 94250991f78ea56810412d00a4bb645eb975478c | |
| ToppCell | distal-mesenchymal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.64e-06 | 200 | 135 | 7 | b54137a4545690f51e154bb05964eaa650c3ca8e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.64e-06 | 200 | 135 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.64e-06 | 200 | 135 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.64e-06 | 200 | 135 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-06 | 200 | 135 | 7 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.64e-06 | 200 | 135 | 7 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-06 | 200 | 135 | 7 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.64e-06 | 200 | 135 | 7 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| Computational | IGFBPs. | 8.32e-05 | 12 | 80 | 3 | MODULE_190 | |
| Computational | Genes in the cancer module 474. | 2.50e-04 | 17 | 80 | 3 | MODULE_474 | |
| Drug | pyraclofos | 2.43e-06 | 106 | 129 | 7 | CID000093460 | |
| Drug | verapamil | CACNA1C CACNA1D KCNH7 VWF CFHR4 CKMT2 GTF3A ABCA6 KCNH1 PRKCE PRKCG PRKCZ KCNH5 | 4.41e-06 | 490 | 129 | 13 | CID000002520 |
| Drug | K 252 | 1.09e-05 | 88 | 129 | 6 | CID000003813 | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.31e-05 | 190 | 129 | 8 | 7145_DN | |
| Drug | chloroform | 1.39e-05 | 138 | 129 | 7 | CID000006212 | |
| Drug | beta-tocopherol | 1.56e-05 | 27 | 129 | 4 | CID000008989 | |
| Drug | NCDC | 1.81e-05 | 28 | 129 | 4 | CID000001583 | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.83e-05 | 199 | 129 | 8 | 5535_DN | |
| Drug | WAY-123,398 | 2.07e-05 | 10 | 129 | 3 | CID000132160 | |
| Drug | Folic Acid | 3.19e-05 | 2 | 129 | 2 | DB00158 | |
| Drug | DCP-LA | 3.19e-05 | 2 | 129 | 2 | CID009904718 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 1.82e-06 | 46 | 130 | 5 | DOID:5426 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.38e-05 | 69 | 130 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | zinc finger protein 329 measurement | 1.93e-05 | 2 | 130 | 2 | EFO_0803276 | |
| Disease | phosphopantothenoylcysteine decarboxylase measurement | 1.93e-05 | 2 | 130 | 2 | EFO_0802867 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.93e-05 | 2 | 130 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.93e-05 | 2 | 130 | 2 | cv:C4551859 | |
| Disease | level of otoraplin in blood serum | 1.93e-05 | 2 | 130 | 2 | OBA_2042720 | |
| Disease | Menke-Hennekam syndrome | 1.93e-05 | 2 | 130 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.93e-05 | 2 | 130 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.93e-05 | 2 | 130 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.93e-05 | 2 | 130 | 2 | C4551859 | |
| Disease | leucine-rich repeat-containing protein 19 measurement | 1.93e-05 | 2 | 130 | 2 | EFO_0801762 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.93e-05 | 2 | 130 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | protein FAM209B measurement | 1.93e-05 | 2 | 130 | 2 | EFO_0802943 | |
| Disease | Rubinstein-Taybi Syndrome | 1.93e-05 | 2 | 130 | 2 | C0035934 | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.31e-05 | 13 | 130 | 3 | DOID:2531 (implicated_via_orthology) | |
| Disease | Proteinuria | 3.66e-05 | 15 | 130 | 3 | HP_0000093 | |
| Disease | calnexin measurement | 5.76e-05 | 3 | 130 | 2 | EFO_0801444 | |
| Disease | complement factor H-related protein 4A measurement | 5.76e-05 | 3 | 130 | 2 | EFO_0600057 | |
| Disease | level of alpha-N-acetylglucosaminidase in blood serum | 5.76e-05 | 3 | 130 | 2 | OBA_2042500 | |
| Disease | soluble transferrin receptor measurement | 5.76e-05 | 3 | 130 | 2 | EFO_0004460 | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 5.76e-05 | 3 | 130 | 2 | EFO_0801683 | |
| Disease | Neurodevelopmental Disorders | 5.85e-05 | 93 | 130 | 5 | C1535926 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 1.15e-04 | 4 | 130 | 2 | EFO_0803292 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.15e-04 | 4 | 130 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | kallikrein-5 measurement | 1.15e-04 | 4 | 130 | 2 | EFO_0020515 | |
| Disease | body weight | SFMBT1 CACNA1C RELN RASA2 VPS13C SPATA31C2 ANO1 THSD7B TRIM27 SPATA31C1 SETD2 LPP PRKCE LTBP1 LTBP2 TEX46 | 1.40e-04 | 1261 | 130 | 16 | EFO_0004338 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.55e-04 | 61 | 130 | 4 | C1961102 | |
| Disease | diastolic blood pressure, systolic blood pressure | COL4A2 CACNA1C CACNA1D AHCYL1 ANK2 ANO1 WDR43 CMIP ARID5B PRKCE PDE11A | 1.93e-04 | 670 | 130 | 11 | EFO_0006335, EFO_0006336 |
| Disease | renal overload-type gout | 2.86e-04 | 6 | 130 | 2 | EFO_0021525 | |
| Disease | complement C1s subcomponent measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0008091 | |
| Disease | pyridoxate measurement | 3.43e-04 | 31 | 130 | 3 | EFO_0010527 | |
| Disease | stem Cell Growth Factor beta measurement | 3.43e-04 | 75 | 130 | 4 | EFO_0008292 | |
| Disease | Complement deficiency disease | 4.14e-04 | 33 | 130 | 3 | C0272242 | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 5.30e-04 | 8 | 130 | 2 | DOID:1312 (is_marker_for) | |
| Disease | eosinophil cationic protein measurement | 5.30e-04 | 8 | 130 | 2 | EFO_0010913 | |
| Disease | DNA repair protein XRCC4 measurement | 5.30e-04 | 8 | 130 | 2 | EFO_0801532 | |
| Disease | Craniofacial Abnormalities | 6.52e-04 | 156 | 130 | 5 | C0376634 | |
| Disease | Atypical hemolytic-uremic syndrome | 6.80e-04 | 9 | 130 | 2 | cv:C2931788 | |
| Disease | longitudinal alcohol consumption measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0007645 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 6.80e-04 | 9 | 130 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | Hemolytic-uremic syndrome | 6.80e-04 | 9 | 130 | 2 | cv:C0019061 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0801766 | |
| Disease | osteoarthritis, hip | 7.45e-04 | 92 | 130 | 4 | EFO_1000786 | |
| Disease | alopecia areata (is_marker_for) | 8.47e-04 | 10 | 130 | 2 | DOID:986 (is_marker_for) | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 8.47e-04 | 10 | 130 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | VWF ANK2 FOLR2 RNF149 CFP SETD2 NLRP9 IGFBP5 KCNH1 SNAI2 RIC8A USP54 EP300 | 9.40e-04 | 1074 | 130 | 13 | C0006142 |
| Disease | Adenoid Cystic Carcinoma | 1.02e-03 | 100 | 130 | 4 | C0010606 | |
| Disease | hemopexin measurement | 1.03e-03 | 11 | 130 | 2 | EFO_0008149 | |
| Disease | Marfan Syndrome | 1.03e-03 | 11 | 130 | 2 | C0024796 | |
| Disease | autoimmune disease | 1.04e-03 | 173 | 130 | 5 | EFO_0005140 | |
| Disease | Leukemia, Myelocytic, Acute | 1.04e-03 | 173 | 130 | 5 | C0023467 | |
| Disease | Autistic Disorder | 1.08e-03 | 261 | 130 | 6 | C0004352 | |
| Disease | Endogenous depression | 1.10e-03 | 46 | 130 | 3 | C0011573 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.24e-03 | 12 | 130 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.41e-03 | 50 | 130 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | liver cirrhosis (implicated_via_orthology) | 1.46e-03 | 13 | 130 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | egg allergy measurement, parental genotype effect measurement | 1.46e-03 | 13 | 130 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | adipic acid mesurement | 1.46e-03 | 13 | 130 | 2 | EFO_0010455 | |
| Disease | atrial fibrillation (is_implicated_in) | 1.69e-03 | 14 | 130 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | Hepatomegaly | 1.76e-03 | 54 | 130 | 3 | C0019209 | |
| Disease | Small cell carcinoma of lung | 1.76e-03 | 54 | 130 | 3 | C0149925 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.76e-03 | 195 | 130 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | calcium measurement | 1.91e-03 | 628 | 130 | 9 | EFO_0004838 | |
| Disease | phosphoenolpyruvic acid measurement | 1.95e-03 | 15 | 130 | 2 | EFO_0010522 | |
| Disease | Replication Error Phenotype | 1.95e-03 | 15 | 130 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 1.95e-03 | 15 | 130 | 2 | C0920269 | |
| Disease | complement factor H-related protein 1 measurement | 1.95e-03 | 56 | 130 | 3 | EFO_0600054 | |
| Disease | risk-taking behaviour | CACNA1C CACNA1D RELN TMEM63C THSD7B TRIM27 RRP12 ARID5B PRKCZ EP300 | 2.10e-03 | 764 | 130 | 10 | EFO_0008579 |
| Disease | pursuit maintenance gain measurement | 2.18e-03 | 123 | 130 | 4 | EFO_0008433 | |
| Disease | amygdala volume change measurement | 2.22e-03 | 16 | 130 | 2 | EFO_0021490 | |
| Disease | T-Cell Lymphoma | 2.22e-03 | 16 | 130 | 2 | C0079772 | |
| Disease | Liver Cirrhosis, Experimental | 2.30e-03 | 774 | 130 | 10 | C0023893 | |
| Disease | Eye Abnormalities | 2.51e-03 | 17 | 130 | 2 | C0015393 | |
| Disease | Calcium channel blocker use measurement | 2.58e-03 | 213 | 130 | 5 | EFO_0009930 | |
| Disease | susceptibility to cold sores measurement | 2.99e-03 | 65 | 130 | 3 | EFO_0008402 | |
| Disease | acute lymphoblastic leukemia | 3.12e-03 | 66 | 130 | 3 | EFO_0000220 | |
| Disease | bipolar disorder (is_marker_for) | 3.14e-03 | 19 | 130 | 2 | DOID:3312 (is_marker_for) | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 3.14e-03 | 19 | 130 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | factor VIII measurement, Ischemic stroke | 3.14e-03 | 19 | 130 | 2 | EFO_0004630, HP_0002140 | |
| Disease | reasoning | 3.14e-03 | 19 | 130 | 2 | EFO_0004350 | |
| Disease | coagulation factor measurement | 3.47e-03 | 20 | 130 | 2 | EFO_0004634 | |
| Disease | alpha-tocopherol measurement | 3.47e-03 | 20 | 130 | 2 | EFO_0007898 | |
| Disease | Bladder Neoplasm | 3.48e-03 | 140 | 130 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.56e-03 | 141 | 130 | 4 | C0005684 | |
| Disease | Non-alcoholic Fatty Liver Disease | 3.69e-03 | 70 | 130 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 3.69e-03 | 70 | 130 | 3 | C3241937 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.74e-03 | 447 | 130 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | kidney disease (biomarker_via_orthology) | 3.83e-03 | 21 | 130 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | Manic Disorder | 3.84e-03 | 71 | 130 | 3 | C0024713 | |
| Disease | Colorectal Carcinoma | 3.99e-03 | 702 | 130 | 9 | C0009402 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 4.13e-03 | 147 | 130 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 4.31e-03 | 74 | 130 | 3 | DOID:3748 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REESSIHCKRCLFMP | 216 | Q9H2P0 | |
| VRQCNLPHCRTMKNV | 361 | Q09472 | |
| VKARSILCCMRHQPN | 146 | P00813 | |
| TNEHTLPKCRDTMRD | 86 | Q8TDH9 | |
| LTHMLPVQICEKCSL | 331 | P22674 | |
| CNTKRLHCFPILMNI | 966 | Q8N139 | |
| LERVKIRPMEHCCCS | 206 | Q8IZP9 | |
| FCKHCRERPRSMVVI | 246 | Q8IY22 | |
| EVRACSLPHCRTMKN | 376 | Q92793 | |
| GLIRTHISRCQVCMK | 1696 | P08572 | |
| CSCRMEAPKIDRISE | 426 | Q96KQ7 | |
| EVRRCSMPSVICEHT | 1306 | Q6UB98 | |
| ELCCASRKPTMAEAR | 1201 | Q9Y4F5 | |
| PDHSSCRIERFLQMC | 706 | Q96HY7 | |
| TKKMCTRSLRCPQHT | 216 | Q14CW9 | |
| LTRKDLCAAMNRPCE | 341 | Q9UKP4 | |
| SCMRKGTHLLVPCLE | 51 | Q7Z3H0 | |
| KPLHCLSIMNRRVCT | 126 | Q96RD1 | |
| PHKMRDCFCTINLDQ | 56 | Q15283 | |
| NSEKHQRVLECLMAC | 546 | Q9NVM9 | |
| AFCIRSLMDVKHSCP | 46 | A0A1B0GVX0 | |
| SLMDVKHSCPVCQRE | 51 | A0A1B0GVX0 | |
| SHDPIEARLRCFCMT | 1336 | Q01484 | |
| RANIEELRCAMPRSC | 246 | D6REC4 | |
| LNCHRMKPALFSVLC | 71 | P40426 | |
| PASEEDMTKLCNHRR | 91 | Q96DN6 | |
| KPCMRVEVVDKRHLC | 286 | Q05BQ5 | |
| RPDVMQKPCTCDFLH | 56 | Q9NS40 | |
| CKMNVHRRCETNVAP | 276 | Q02156 | |
| SICPKDMRADICVHL | 526 | Q8NCM2 | |
| TGKVMIRIHPCARLC | 286 | Q9P1W3 | |
| CFCTHPMVLDASEKR | 1491 | Q14766 | |
| MHRAQTLLKCERCSV | 411 | Q9HCR9 | |
| MPALACLRRLCRHVS | 1 | P52848 | |
| ATVARMKPHCAICTL | 636 | Q9H3R0 | |
| LQICPKDMRADICVH | 556 | O95259 | |
| CNVCSKPIMERILRA | 476 | Q93052 | |
| MVHCAGCKRPILDRF | 1 | P48742 | |
| KMEPTCKRHFIQDSC | 91 | P41439 | |
| PCRRHMEASLQELKA | 191 | P24593 | |
| MNVHRRCVRSVPSLC | 136 | P05129 | |
| KLLCEVMREPSCHLQ | 1026 | P59047 | |
| DQRHNITMCPLCDKT | 371 | Q5XXA6 | |
| MAEHFKQIIRCPVCL | 1 | A6NLU0 | |
| PCIRRNMKSISCQEI | 326 | P27918 | |
| LPMCRNKFIDHISCE | 166 | Q13607 | |
| ECVEPNCRSKRMLAI | 71 | Q969Q0 | |
| NMTSCHRPICRKEGV | 2961 | P78509 | |
| CHRMKPALFSVLCEI | 46 | Q9BYU1 | |
| LVRMHAICPRDDSDC | 431 | Q9BXL6 | |
| LCPHRVACKRLVSMN | 1581 | Q13936 | |
| CIDVVQCPKMRRHAF | 226 | Q5JSL3 | |
| HLMRSAKERVRQDPC | 126 | Q9BQI3 | |
| DLIEENCRMRKTSPC | 466 | Q5THR3 | |
| EKQSRLCMVRPCEAD | 231 | P29279 | |
| ILLTMCEDQPHRRCT | 136 | Q68DX3 | |
| EMERSPQLRKHACRV | 71 | Q8WWM9 | |
| KNLPLRLAHCRSTME | 76 | Q5T5S1 | |
| MEPACKRHFIQDTCL | 86 | P14207 | |
| RCIHPCIITEENMNK | 511 | Q92496 | |
| CHMDLTREVCPLTVK | 216 | Q8IY82 | |
| IMVRKGHCQDINECR | 961 | Q14767 | |
| LRAMKLPSISCPHEC | 41 | Q6UWN5 | |
| CQTLLGLIKDEMCRH | 446 | Q92538 | |
| CPVCDRRFMRSDHLT | 456 | O14901 | |
| KCLHPCVISREIMEN | 261 | Q03591 | |
| AICDSEMRSCKPLTR | 226 | Q6ZVF9 | |
| MSCCLSSRVHITRPV | 1 | P0C6P0 | |
| PMTAENFRCLCTHEK | 166 | Q9UNP9 | |
| KLRSMIPCCLCHVNF | 761 | Q86YS7 | |
| LCPHRVACKRLVAMN | 1521 | Q01668 | |
| CIMRPLSKDACSRVR | 51 | Q68BL7 | |
| MRLTIPCRAVTCTHL | 351 | O75928 | |
| DLRKHNNCMAECLTP | 56 | P17540 | |
| LIAPCTCDAHQRTRM | 1001 | A6NES4 | |
| HSARMTLAKACELCP | 2461 | Q93008 | |
| MAEHFKQIIRCPVCL | 1 | F8VTS6 | |
| QMPICVVCDRSREHR | 111 | P14373 | |
| FICMEKLRDARLCPH | 16 | O94972 | |
| RMKNHSLRACRECPR | 81 | B4DYI2 | |
| QCVSAKSPQHCMERI | 396 | P08582 | |
| VSKICPLMISRNHCV | 51 | O76064 | |
| ECVEPNCRSKRMLAI | 71 | P83881 | |
| IKHTKIPIICMCNDR | 741 | P35251 | |
| TREHLDRMKNSCIVC | 381 | O43865 | |
| KICVKNVPCDSEHMR | 1466 | Q9HCM1 | |
| AEQKCPDHSMRIRII | 161 | Q8N6K7 | |
| KHCESEQRCLDRLMV | 691 | P27987 | |
| CPHCTKRLKNNIRFM | 496 | Q7Z3K3 | |
| MHIRTHTLPCVCKIC | 176 | O43623 | |
| RAFRKQMEDCCDPAH | 76 | Q92185 | |
| HPCVESMKDNVLRDR | 481 | P37173 | |
| EKRCTKIMTCVRPNH | 51 | Q8NEX5 | |
| RENRTEKCPLMNVEH | 651 | Q96JS3 | |
| GRMKNHSLRACRECP | 86 | P0DKV0 | |
| PRCVERHCSTFQMPK | 491 | Q4LDE5 | |
| SVLTECARMHRPARK | 336 | Q9NPQ8 | |
| HPVMRKCLQSLCDLR | 506 | Q5JTH9 | |
| QSRDCHPKACRVSPM | 946 | Q14865 | |
| DIRHLCETLKHPMCK | 701 | Q7RTR0 | |
| LPTLRHMDRDTVKAC | 101 | Q6URK8 | |
| KMRLTVPCRALTCAH | 331 | Q9Y6X2 | |
| REHSQTCQRPKCCML | 111 | A6NCW0 | |
| LDHRTCPMCKLDVIK | 301 | Q8NC42 | |
| EKLHTADRPFVCEMC | 296 | O43829 | |
| KEERMDSARPCLHRQ | 421 | Q92574 | |
| CHVCRKVLTSSRNLM | 876 | O14709 | |
| REHSQTCQRPKCCML | 111 | A6NCW7 | |
| EIQARVRHRCPMSSK | 101 | Q15697 | |
| HEVLNAMECKCSPRK | 2796 | P04275 | |
| LLRHSKDRFPDIMTC | 136 | Q9NV58 | |
| PKMRLRFRDTNGHCC | 151 | Q12974 | |
| AGLRTCCHQKLEDMI | 1341 | A6NE52 | |
| SKVDHNVPRHRCMLC | 536 | Q8IZM8 | |
| NVPRHRCMLCNKEFL | 541 | Q8IZM8 | |
| SMTDICKSDNPCHRN | 321 | Q8WWQ8 | |
| HRSREVRCMLQCPSV | 2616 | Q709C8 | |
| VKSLPRCHMVSRERL | 176 | Q9Y6S9 | |
| MRRLLAQHATSECPK | 176 | Q9BUZ4 | |
| REHSQTCQRPKCCML | 111 | Q7RTZ2 | |
| MRLSVPCRAETCAHL | 331 | Q8N2W9 | |
| HRDIKRMQCECTPLS | 1491 | Q9BYW2 | |
| RMQCECTPLSKDERA | 1496 | Q9BYW2 | |
| SCKCDSHRMNLPVAS | 136 | Q5TYW1 | |
| CPECDKNFRERGHML | 706 | Q8N393 | |
| REHSQTCQRPKCCML | 111 | P0C7I0 | |
| PRMVLDKCSENCSVL | 616 | Q9UHJ3 | |
| MKTHAPERDVCRCPR | 236 | Q92664 | |
| RMIHTGEKPLQCEIC | 391 | Q96JP5 | |
| VRSRHQLAMLCSPCI | 456 | Q92508 | |
| PQKRCLFVCRHGERM | 381 | Q8TF42 | |
| RKSCEIPCRMDCVLS | 591 | Q9C0I4 | |
| PRCPTDCEKQRARMQ | 656 | P01266 | |
| RMRRHESICPTLSDC | 101 | H3BTG2 | |
| HRCMETTPSLACANK | 341 | Q6NUM6 | |
| REHSQTCQRPKCCML | 111 | Q6R6M4 | |
| SREPHMCLVRDISNC | 366 | Q15061 | |
| CNQAICMLERREKPS | 191 | Q70EL1 | |
| RCHGLVPLTCRKHMD | 171 | Q05513 |